Artificial intelligence for differentiating COVID-19 from other viral pneumonias on CT: comparative analysis of different models based on quantitative and radiomic approaches.


Journal

European radiology experimental
ISSN: 2509-9280
Titre abrégé: Eur Radiol Exp
Pays: England
ID NLM: 101721752

Informations de publication

Date de publication:
24 Jan 2023
Historique:
received: 06 09 2022
accepted: 15 12 2022
entrez: 23 1 2023
pubmed: 24 1 2023
medline: 26 1 2023
Statut: epublish

Résumé

To develop a pipeline for automatic extraction of quantitative metrics and radiomic features from lung computed tomography (CT) and develop artificial intelligence (AI) models supporting differential diagnosis between coronavirus disease 2019 (COVID-19) and other viral pneumonia (non-COVID-19). Chest CT of 1,031 patients (811 for model building; 220 as independent validation set (IVS) with positive swab for severe acute respiratory syndrome coronavirus-2 (647 COVID-19) or other respiratory viruses (384 non-COVID-19) were segmented automatically. A Gaussian model, based on the HU histogram distribution describing well-aerated and ill portions, was optimised to calculate quantitative metrics (QM, n = 20) in both lungs (2L) and four geometrical subdivisions (GS) (upper front, lower front, upper dorsal, lower dorsal; n = 80). Radiomic features (RF) of first (RF1, n = 18) and second (RF2, n = 120) order were extracted from 2L using PyRadiomics tool. Extracted metrics were used to develop four multilayer-perceptron classifiers, built with different combinations of QM and RF: Model1 (RF1-2L); Model2 (QM-2L, QM-GS); Model3 (RF1-2L, RF2-2L); Model4 (RF1-2L, QM-2L, GS-2L, RF2-2L). The classifiers showed accuracy from 0.71 to 0.80 and area under the receiving operating characteristic curve (AUC) from 0.77 to 0.87 in differentiating COVID-19 versus non-COVID-19 pneumonia. Best results were associated with Model3 (AUC 0.867 ± 0.008) and Model4 (AUC 0.870 ± 0.011. For the IVS, the AUC values were 0.834 ± 0.008 for Model3 and 0.828 ± 0.011 for Model4. Four AI-based models for classifying patients as COVID-19 or non-COVID-19 viral pneumonia showed good diagnostic performances that could support clinical decisions.

Sections du résumé

BACKGROUND BACKGROUND
To develop a pipeline for automatic extraction of quantitative metrics and radiomic features from lung computed tomography (CT) and develop artificial intelligence (AI) models supporting differential diagnosis between coronavirus disease 2019 (COVID-19) and other viral pneumonia (non-COVID-19).
METHODS METHODS
Chest CT of 1,031 patients (811 for model building; 220 as independent validation set (IVS) with positive swab for severe acute respiratory syndrome coronavirus-2 (647 COVID-19) or other respiratory viruses (384 non-COVID-19) were segmented automatically. A Gaussian model, based on the HU histogram distribution describing well-aerated and ill portions, was optimised to calculate quantitative metrics (QM, n = 20) in both lungs (2L) and four geometrical subdivisions (GS) (upper front, lower front, upper dorsal, lower dorsal; n = 80). Radiomic features (RF) of first (RF1, n = 18) and second (RF2, n = 120) order were extracted from 2L using PyRadiomics tool. Extracted metrics were used to develop four multilayer-perceptron classifiers, built with different combinations of QM and RF: Model1 (RF1-2L); Model2 (QM-2L, QM-GS); Model3 (RF1-2L, RF2-2L); Model4 (RF1-2L, QM-2L, GS-2L, RF2-2L).
RESULTS RESULTS
The classifiers showed accuracy from 0.71 to 0.80 and area under the receiving operating characteristic curve (AUC) from 0.77 to 0.87 in differentiating COVID-19 versus non-COVID-19 pneumonia. Best results were associated with Model3 (AUC 0.867 ± 0.008) and Model4 (AUC 0.870 ± 0.011. For the IVS, the AUC values were 0.834 ± 0.008 for Model3 and 0.828 ± 0.011 for Model4.
CONCLUSIONS CONCLUSIONS
Four AI-based models for classifying patients as COVID-19 or non-COVID-19 viral pneumonia showed good diagnostic performances that could support clinical decisions.

Identifiants

pubmed: 36690869
doi: 10.1186/s41747-022-00317-6
pii: 10.1186/s41747-022-00317-6
pmc: PMC9870776
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Informations de copyright

© 2023. The Author(s).

Références

Radiographics. 2020 Jul-Aug;40(4):E8-E15
pubmed: 32501740
Phys Med. 2021 Jul;87:115-122
pubmed: 34139383
Diagnostics (Basel). 2022 Mar 31;12(4):
pubmed: 35453917
Radiology. 2020 Aug;296(2):E46-E54
pubmed: 32155105
PeerJ Comput Sci. 2021 May 26;7:e564
pubmed: 34141890
Ann Transl Med. 2021 Jan;9(2):111
pubmed: 33569413
J Comput Assist Tomogr. 2009 Sep-Oct;33(5):731-8
pubmed: 19820502
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1478-1486
pubmed: 33094432
Eur J Radiol. 2021 May;138:109650
pubmed: 33743491
Eur J Radiol. 2021 Mar;136:109552
pubmed: 33497881
Nat Commun. 2020 Oct 9;11(1):5088
pubmed: 33037212
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222
Sci Rep. 2020 Jan 15;10(1):338
pubmed: 31941918
Radiology. 2022 Jun;303(3):682-692
pubmed: 35103535
Theranostics. 2020 Jun 5;10(16):7231-7244
pubmed: 32641989
Radiology. 2020 Jul;296(1):172-180
pubmed: 32255413
Diagn Interv Imaging. 2020 May;101(5):263-268
pubmed: 32291197
Phys Med. 2021 May;85:63-71
pubmed: 33971530
Phys Med. 2021 Feb;82:28-39
pubmed: 33567361
Radiol Med. 2021 Aug;126(8):1037-1043
pubmed: 34043146
Radiology. 2020 Sep;296(3):E156-E165
pubmed: 32339081
Eur J Radiol Open. 2020;7:100271
pubmed: 32959017
Nat Commun. 2020 Aug 14;11(1):4080
pubmed: 32796848
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Radiology. 2022 Sep 27;:221795
pubmed: 36165791
Acad Radiol. 2015 May;22(5):626-31
pubmed: 25728361
Radiology. 2020 Aug;296(2):E86-E96
pubmed: 32301647
AJR Am J Roentgenol. 2020 May;214(5):1072-1077
pubmed: 32125873
Comput Methods Programs Biomed. 2020 Nov;196:105608
pubmed: 32599338
Eur Radiol. 2022 Sep;32(9):5787-5789
pubmed: 35348862
Anesthesiology. 1988 Dec;69(6):824-32
pubmed: 3057937
Eur Radiol. 2021 Mar;31(3):1770-1779
pubmed: 32945968
Lancet Digit Health. 2020 Oct;2(10):e506-e515
pubmed: 32984796
Eur Radiol Exp. 2020 Aug 20;4(1):50
pubmed: 32814998
Ann Oncol. 2017 Jun 1;28(6):1191-1206
pubmed: 28168275
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
Eur J Radiol. 2021 Dec;145:110028
pubmed: 34839214

Auteurs

Giulia Zorzi (G)

Postgraduate School of Medical Physics, Università degli Studi di Milano, via Giovanni Celoria 16, 20133, Milan, Italy.
Department of Medical Physics, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.
Department of Physics, INFN Sezione di Milano, via Giovanni Celoria 16, 20133, Milan, Italy.

Luca Berta (L)

Department of Medical Physics, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy. luca.berta@ospedaleniguarda.it.

Francesco Rizzetto (F)

Postgraduate School of Diagnostic and Interventional Radiology, Università degli Studi di Milano, via Festa del Perdono 7, 20122, Milan, Italy. francesco.rizzetto@unimi.it.
Department of Radiology, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy. francesco.rizzetto@unimi.it.

Cristina De Mattia (C)

Department of Medical Physics, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.

Marco Maria Jacopo Felisi (MMJ)

Department of Medical Physics, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.

Stefano Carrazza (S)

Department of Physics, INFN Sezione di Milano, via Giovanni Celoria 16, 20133, Milan, Italy.
Department of Physics, Università degli Studi di Milano, via Giovanni Celoria 16, 20133, Milan, Italy.

Silvia Nerini Molteni (S)

Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Chiara Vismara (C)

Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Francesco Scaglione (F)

Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, via Festa del Perdono 7, 20122, Milan, Italy.

Angelo Vanzulli (A)

Department of Radiology, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.
Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, via Festa del Perdono 7, 20122, Milan, Italy.

Alberto Torresin (A)

Department of Medical Physics, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.
Department of Physics, INFN Sezione di Milano, via Giovanni Celoria 16, 20133, Milan, Italy.
Department of Physics, Università degli Studi di Milano, via Giovanni Celoria 16, 20133, Milan, Italy.

Paola Enrica Colombo (PE)

Department of Medical Physics, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.
Department of Physics, Università degli Studi di Milano, via Giovanni Celoria 16, 20133, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH